A new, greener process with lower manufacturing costs - MPTxpress

MicroProtein Technologies is the first company to produce recombinant biologics on an industrial scale without employing the conventional fermentation process.
Our facilities and CMO services are now cGMP certified.

Learn More

Latest News October 2021:  MicroProtein Technologies now offers product Human IL-2 October 2021: MicroProtein Technologies now offers product Streptavidin May 2021:  MicroProtein Receives ISO 9001:2015 GMP Certification April 2018:  J. Schroeder Joins MicroProtein Technologies as Director of Quality April 2018:  S.R. Rangineni, M.D., has Joined MicroProtein as Vice President of Business Development and Strategy

MPT Clients/Customers Asahi Kasei
AnaptysBio Inc
Beckman Coulter
Entera Health
GT Biopharma
Kane Biotech
LakePharma Inc
Luna Nanotech
Life Technologies Corporation
Medella Health
Median Biotech
Median Diagnostics
Natrix Separations Inc/MilliporeSigma
New EnglandBioLabs
National Institute of Health
Ocean Nanotech
Puridify/GE Healthcare
Rush University Medical Center
ScienTech Corp
SciGenome Labs
Stanford University
StemCell Technologies
Takara Bio USA Inc
University of Arkansas Medical Center
Vircell Microbiologists